ArticleTropical medicine and infectious disease2021
Extended Spectrum Beta-Lactamase
Abstract read
In one paragraph
Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Genomic epidemiology of extended-spectrum beta-lactamase-producingJAC-antimicrobial resistance · 2026Article
- Frequency and characteristics of extended-spectrum beta-lactamase-producing Escherichia coli in wastewater in Dakar, Senegal.BMC research notes · 2026Article
- Third generation cephalosporin-resistant (3GCR) Escherichia coli and biocide-tolerant heterotrophic bacteria in irrigation water used in Capsicum annuum cultivation areas in Kosovo.Scientific reports · 2026Article
- Linking wet-lab and genomic approaches for reliable detection of carbapenemase-producingFrontiers in microbiology · 2026Article
- Stakeholder views on the implementation of the UK's Antimicrobial Resistance (AMR) National Action Plan (2019-2024) in relation to AMR in the environment.Global health action · 2025Article
- Antibiotic-Resistant Bacteria in Drinking Water Across Twelve Regions of Ghana: Strengthening Evidence for National Surveillance.Tropical medicine and infectious disease · 2025Article
- A 15-Minute Exposure to Locally Available Disinfectants EliminatesTropical medicine and infectious disease · 2025Article
- Evaluation of a modified IDEXX method for antimicrobial resistance monitoring of extended Beta-lactamases-producingOne health (Amsterdam, Netherlands) · 2025Article
- Environmental Risk Factors Contributing to the Spread of Antibiotic Resistance in West Africa.Microorganisms · 2025Review
- Sources and Transmission Routes of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Article
- Urban wastewater overflows as hotspots for dissemination of bacteria producing extended-spectrum β-lactamases and carbapenemases in the Suquía River, Argentina.Frontiers in microbiology · 2025Article
- Genotyping of extended-spectrum beta-lactamase-producingVeterinary world · 2025Article
- Genomic epidemiology of extended-spectrum beta-lactamase-producingMicrobial genomics · 2025Article
- Human-environmental overlap of resistant Enterobacterales: genomic evidence linking coastal waters and community carriage of antimicrobial resistance in a low- and middle-income setting.Frontiers in antibiotics · 2025Article
- Barriers and pathways to environmental surveillance of antibiotic resistance in middle- and low-income settings: a qualitative exploratory key expert study.Global health action · 2024Article
- Prevalence, Antimicrobial Susceptibility, and Resistance Genes of Extended-Spectrum β-Lactamase-ProducingMicroorganisms · 2024Article
- Key environmental exposure pathways to antimicrobial resistant bacteria in southern Malawi: A SaniPath approach.The Science of the total environment · 2024Article
- Extended-spectrum beta-lactamase (ESBL)- and non-ESBL producing Escherichia coli surveillance in surface water sources in Edo State, Nigeria: a public health concern.Scientific reports · 2024Article
- Carbapenem- and cefiderocol-resistantJAC-antimicrobial resistance · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Regina Ama BanuCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.
Jorge Matheu AlvarezDepartment of Surveillance Prevention and Control of AMR, AMR Division, World Health Organization, Route de Sauverny 22, 1290 Versoix, Switzerland.
Anthony J ReidOperational Research Unit (LuxOR), Medical Department, Médecins Sans Frontières Operational Centre Brussels, L-1617 Luxembourg, Luxembourg.
Wendemagegn EnbialeDermatovenereology Department, BahirDar Department University, BahirDar P.O. Box 1996, Ethiopia.ORCID 0000-0002-0692-850X
Appiah-Korang LabiWHO Country Office, Ghana, 7 Ameda Street, Roman Ridge, Accra P.O. Box MB 142, Ghana.
Ebenezer D O AnsaCouncil for Scientific and Industrial Research-Animal Research Institute, Adenta-Frafraha, Achimota-Accra P.O. Box AH 20, Ghana.
Edith Andrews AnnanWorld Health Organization, Harare, Zimbabwe.
Mark Osa AkrongCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.
Selorm BorborCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.
Lady A B AdomakoCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.ORCID 0000-0002-9478-0057
Hawa AhmedCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.ORCID 0000-0003-4790-152X
Mohammed Bello MustaphaCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.
Hayk DavtyanTuberculosis Research and Prevention Center NGO, Yerevan 0040, Armenia.ORCID 0000-0002-9836-4261
Phillip OwitiThe International Union against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France.
George Kwesi HedidorWHO Country Office, Ghana, 7 Ameda Street, Roman Ridge, Accra P.O. Box MB 142, Ghana.
Gerard QuarcooCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.ORCID 0000-0003-3743-020X
David OpareNational Public Health & Reference Laboratory Ghana Health Service, Accra P.O. Box 300, Ghana.
Boi KikimotoNational Food Safety/AMR Reference Laboratory for Animal Health (Terrestrial & Aquatic Animals), Veterinary Services, Accra P.O. Box M 161, Ghana.
Mike Y Osei-AtwenebanoaCSIR-Water Research Institute, Council for Scientific and Industrial Research, 2nd CSIR Close, Achimota, Accra P.O. Box AH 38, Ghana.ORCID 0000-0002-8541-5015
Heike SchmittCentre for Zoonoses and Environmental Microbiology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.
Funding
World Health Organization 001
Abstract
Infections by Extended-Spectrum Beta-Lactamase producing
Indexed as
antimicrobial resistanceenvironmentESBL-E. coliGhanaoperational researchriverssort ittricycle protocol
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.